Leukemic stem cell: a mini-review on clinical perspectives (2022)
Source: Frontiers in Oncology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, LEUCEMIA, BIOMARCADORES, RECIDIVA, MEDICAMENTO
ABNT
BARRETO, Igor Valentim et al. Leukemic stem cell: a mini-review on clinical perspectives. Frontiers in Oncology, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.931050. Acesso em: 27 jan. 2026.APA
Barreto, I. V., Pessoa, F. M. C. de P., Machado, C. B., Pantoja, L. da C., Ribeiro, R. M., Lopes, G. S., et al. (2022). Leukemic stem cell: a mini-review on clinical perspectives. Frontiers in Oncology, 12, 1-11. doi:10.3389/fonc.2022.931050NLM
Barreto IV, Pessoa FMC de P, Machado CB, Pantoja L da C, Ribeiro RM, Lopes GS, Moraes MEA de, Moraes Filho MO de, Souza LEB de, Burbano RMR, Khayat AS, Moreira-Nunes CA. Leukemic stem cell: a mini-review on clinical perspectives [Internet]. Frontiers in Oncology. 2022 ; 12 1-11.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3389/fonc.2022.931050Vancouver
Barreto IV, Pessoa FMC de P, Machado CB, Pantoja L da C, Ribeiro RM, Lopes GS, Moraes MEA de, Moraes Filho MO de, Souza LEB de, Burbano RMR, Khayat AS, Moreira-Nunes CA. Leukemic stem cell: a mini-review on clinical perspectives [Internet]. Frontiers in Oncology. 2022 ; 12 1-11.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3389/fonc.2022.931050
